Filing Details

Accession Number:
0000908662-18-000170
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-25 19:16:39
Reporting Period:
2018-06-25
Accepted Time:
2018-06-25 19:16:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346302 Xeris Pharmaceuticals Inc XERS Pharmaceutical Preparations (2834) 203352427
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744226 Palmetto Partners, Ltd. 109 N. Post Oak Lane, Suite 600
Houston TX 77024
No No Yes No
1744227 Palmetto Partners 2014, Lp 109 N. Post Oak Lane, Suite 600
Houston TX 77024
No No Yes No
1744228 Palmetto Partners 2015, Lp 109 N. Post Oak Lane, Suite 600
Houston TX 77024
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-25 930,383 $0.00 930,383 No 4 C Direct
Common Stock Acquisiton 2018-06-25 581,992 $0.00 1,512,375 No 4 C Direct
Common Stock Acquisiton 2018-06-25 447,686 $0.00 1,960,061 No 4 C Direct
Common Stock Acquisiton 2018-06-25 150,000 $15.00 2,110,061 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2018-06-25 1,657,125 $0.00 930,383 $0.00
Common Stock Series B Preferred Stock Disposition 2018-06-25 1,036,599 $0.00 581,992 $0.00
Common Stock Series B Preferred Stock Disposition 2018-06-25 797,384 $0.00 447,686 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The securities are owned by Palmetto Partners, 2014, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2015, LP.
  2. Each share of Preferred Stock automatically converted into Common Stock, for no additional payment or consideration, on a 1.78112-for-1 basis, at the closing of the Issuer's initial public offering on June 25, 2018 and had no expiration date.
  3. The securities are owned by Palmetto Partners 2015, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2014, LP.
  4. The securities are owned by Palmetto Partners, Ltd., who is a member of a group with Palmetto Partners 2014, LP and Palmetto Partners 2015, LP.